New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008

1.

Chetaille B, Bertucci F, Finetti P, Esterni B, Stamatoullas A, Picquenot JM, Copin MC, Morschhauser F, Casasnovas O, Petrella T, Molina T, Vekhoff A, Feugier P, Bouabdallah R, Birnbaum D, Olive D, Xerri L (2009) Molecular profiling of classical Hodgkin’s lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome. Blood (in press)

2.

Asano N, Yamamoto K, Tamaru JI, Oyama T, Ishida F, Ohshima K, Yoshino T,Nakamura N, Mori S, Yoshie O, Shimoyama Y, Morishima Y, Kinoshita T, Nakamura S (2009) Age-related EBV-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classical Hodgkin lymphoma in elderly patients. Blood (in press)

3.

de Jong D, Koster A, Hagenbeek A, Raemaekers J, Veldhuizen D, Heisterkamp S, de Boer JP, van Glabbeke M (2009) Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica 94(1):70–77

4.

van Krieken JH (2008) New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008. J Hematopathol 1:145–160CrossRef

5.

Ai WZ, Hou JZ, Zeiser R, Czerwinski D, Negrin RS, Levy R (2009) Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells. Int J Cancer 124(1):239–244PubMedCrossRef

6.

Chadburn A, Hyjek EM, Tam W, Liu Y, Rengifo T, Cesarman E, Knowles DM (2008) Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD). Histopathology 53(5):513–524PubMed

7.

Mack AA, Sugden B (2008) EBV is necessary for proliferation of dually infected primary effusion lymphoma cells. Cancer Res 68:6963–6968PubMedCrossRef

8.

Everton KL, Abbott DR, Crockett DK, Elenitoba-Johnson KS, Lim MS (2009) Quantitative proteomic analysis of follicular lymphoma cells in response to rituximab. J Chromatogr B Analyt Technol Biomed Life Sci (in press)

9.

Lapalombella R, Yu B, Triantafillou G, Liu Q, Butchar JP, Lozanski G, Ramanunni A, Smith LL, Blum W, Andritsos L, Wang DS, Lehman A, Chen CS, Johnson AJ, Marcucci G, Lee RJ, Lee LJ, Tridandapani S, Muthusamy N, Byrd JC (2008) Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells. Blood 112(13):5180–5189PubMedCrossRef

10.

Jones RJ, Chen Q, Voorhees PM, Young KH, Bruey-Sedano N, Yang D, Orlowski RZ (2008) Inhibition of the p53 E3 ligase HDM-2 induces apoptosis and DNA damage–independent p53 phosphorylation in mantle cell lymphoma. Clin Cancer Res 14(17):5416–5425PubMedCrossRef

11.

Roué G, López-Guerra M, Milpied P, Pérez-Galán P, Villamor N, Montserrat E, Campo E, Colomer D (2008) Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling. Clin Cancer Res 14(21):6907–6915PubMedCrossRef

12.

Dal Col J, Dolcetti R (2008) GSK-3beta inhibition: at the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma. Cell Cycle 7(18):2813–2816PubMed

13.

Schraders M, Jares P, Bea S, Schoenmakers EF, van Krieken JH, Campo E, Groenen PJ (2008) Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes. Br J Haematol 143(2):210–221PubMedCrossRef

14.

Bea S, Salaverria I, Armengol L, Pinyol M, Fernandez V, Hartmann EM, Jares P, Amador V, Hernandez L, Navarro A, Ott G, Rosenwald A, Estivill X, Campo E (2009) Uniparental disomies, homozygous deletions, amplifications and target genes in mantle cell lymphoma revealed by integrative high-resolution whole genome profiling. Blood (in press)

15.

Gelebart P, Anand M, Armanious H, Peters AC, Dien Bard J, Amin HM, Lai R (2008) Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma. Blood 112(13):5171–5179PubMedCrossRef

16.

Kondo E, Maecker B, Weihrauch MR, Wickenhauser C, Zeng W, Nadler LM, Schultze JL, von Bergwelt-Baildon MS (2008) Cyclin D1-specific cytotoxic T lymphocytes are present in the repertoire of cancer patients: implications for cancer immunotherapy. Clin Cancer Res 14(20):6574–6579PubMedCrossRef

17.

Espinosa I, Briones J, Bordes R, Brunet S, Martino R, Sureda A, Sierra J, Prat J (2008) Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications. Histopathology 53(4):441–449PubMedCrossRef

18.

Uddin S, Hussain A, Ahmed M, Belgaumi A, Al-Dayel F, Ajarim D, Bavi P, Al-Kuraya KS (2008) S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma. J Pathol 216(4):483–494PubMedCrossRef

19.

Mason KD, Vandenberg CJ, Scott CL, Wei AH, Cory S, Huang DC, Roberts AW (2008) In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas. Proc Natl Acad Sci USA 105(46):17961–17966PubMedCrossRef

20.

Groen RW, Oud ME, Schilder-Tol EJ, Overdijk MB, ten Berge D, Nusse R, Spaargaren M, Pals ST (2008) Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies. Cancer Res 68(17):6969–6977PubMedCrossRef

21.

Ambrogio C, Voena C, Manazza AD, Martinengo C, Costa C, Kirchhausen T, Hirsch E, Inghirami G, Chiarle R (2008) The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation. Cancer Res 68(21):8899–8907PubMedCrossRef

22.

Marzec M, Zhang Q, Goradia A, Raghunath PN, Liu X, Paessler M, Wang HY, Wysocka M, Cheng M, Ruggeri BA, Wasik MA (2008) Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1). Proc Natl Acad Sci USA 105(52):20852–20857PubMedCrossRef

23.

Shen L, Au WY, Wong KY, Shimizu N, Tsuchiyama J, Kwong YL, Liang RH, Srivastava G (2008) Cell death by bortezomib-induced mitotic catastrophe in natural killer lymphoma cells. Mol Cancer Ther 7(12):3807–3815PubMedCrossRef

24.

Ian MX, Lan SZ, Cheng ZF, Dan H, Qiong LH (2008) Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells. Cancer Biol Ther 7(10):1602–1606PubMedCrossRef

25.

Morton LM, Wang SS, Cozen W, Linet MS, Chatterjee N, Davis S, Severson RK, Colt JS, Vasef MA, Rothman N, Blair A, Bernstein L, Cross AJ, De Roos AJ, Engels EA, Hein DW, Hill DA, Kelemen LE, Lim U, Lynch CF, Schenk M, Wacholder S, Ward MH, Hoar Zahm S, Chanock SJ, Cerhan JR, Hartge P (2008) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood 112(13):5150–5160PubMedCrossRef

26.

Ponzoni M, Ferreri AJ, Guidoboni M, Lettini AA, Cangi MG, Pasini E, Sacchi L, Pecciarini L, Grassi S, Dal Cin E, Stefano R, Magnino S, Dolcetti R, Doglioni C (2008) Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Clin Cancer Res 14(18):5794–5800PubMedCrossRef

27.

Al-Tourah AJ, Gill KK, Chhanabhai M, Hoskins PJ, Klasa RJ, Savage KJ, Sehn LH, Shenkier TN, Gascoyne RD, Connors JM (2008) Population-based analysis of incidence and outcome of transformed non-Hodgkin’s lymphoma. J Clin Oncol 26(32):5165–5169PubMedCrossRef

28.

Nomura Y, Yoshida S, Karube K, Takeshita M, Hirose S, Nakamura S, Yoshino T, Kikuchi M, Ohshima K (2008) Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt’s and Burkitt-like lymphoma. Cancer Sci 99(8):1564–1569PubMedCrossRef

29.

Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM (2008) Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 123(11):2658–2663PubMedCrossRef

30.

Queiroga EM, Gualco G, Weiss LM, Dittmer DP, Araujo I, Klumb CE, Harrington WJ Jr, Bacchi CE (2008) Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features. Am J Clin Pathol 130(6):946–956PubMedCrossRef

31.

Keszler A, Piloni MJ, Paparella ML, Soler Mde D, Ron PC, Narbaitz M (2008) Extranodal oral non-Hodgkin’s lymphomas. A retrospective study of 40 cases in Argentina. Acta Odontol Latinoam 21(1):43–48PubMed

32.

Paul TR, Challa S, Tandon A, Panigrahi MK, Purohit AK (2008) Primary central nervous system lymphomas: Indian experience, and review of literature. Indian J Cancer 45(3):112–118PubMedCrossRef

33.

Benharroch D, Levy A, Gopas J, Sacks M (2008) Lymphocyte-depleted classic Hodgkin lymphoma-a neglected entity. Virchows Arch 453(6):611–616PubMedCrossRef

34.

Brune V, Tiacci E, Pfeil I, Döring C, Eckerle S, van Noesel CJ, Klapper W, Falini B, von Heydebreck A, Metzler D, Bräuninger A, Hansmann ML, Küppers R (2008) Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 205(10):2251–2268PubMedCrossRef

35.

Weinberg OK, Ma L, Seo K, Beck AH, Pai RK, Morales A, Kim Y, Sundram U, Tan D, Horning SJ, Hoppe RT, Natkunam Y, Arber DA (2009) Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin. Am J Surg Pathol (in press)

36.

Lagoo AS, Haggerty C, Kim Y, Hammons M, Neufeld K, Redher C, Woodward J, Klintworth GK (2008) Morphologic features of 115 lymphomas of the orbit and ocular adnexa categorized according to the World Health Organization classification: are marginal zone lymphomas in the orbit mucosa-associated lymphoid tissue-type lymphomas. Arch Pathol Lab Med 132(9):1405–1416PubMed

37.

Sjo LD, Heegaard S, Prause JU, Petersen BL, Pedersen S, Ralfkiaer E (2009) Extranodal marginal zone lymphoma in the ocular region: clinical, immunophenotypical and cytogenetical characteristics. Invest Ophthalmol Vis Sci 50(2):516–522

38.

Takino H, Li C, Hu S, Kuo TT, Geissinger E, Muller-Hermelink HK, Kim B, Swerdlow SH, Inagaki H (2008) Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathological study of cases from Asia, Germany, and the United States. Mod Pathol 21(12):1517–1526PubMedCrossRef

39.

Sinn DH, Kim YH, Lee EJ, Ko YH, Kim KM (2009) Methylation and API2/MALT1 fusion in colorectal extranodal marginal zone lymphoma. Mod Pathol 22(2):314–320

40.

Vinatzer U, Gollinger M, Müllauer L, Raderer M, Chott A, Streubel B (2008) Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3. Clin Cancer Res 14(20):6426–6431PubMedCrossRef

41.

Chanudet E, Ye H, Ferry J, Bacon C, Adam P, Müller-Hermelink H, Radford J, Pileri S, Ichimura K, Collins V, Hamoudi R, Nicholson A, Wotherspoon A, Isaacson P, Du M (2009) A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. J Pathol 217(3):420–430

42.

Sargent RL, Cook JR, Aguilera NI, Surti U, Abbondanzo SL, Gollin SM, Swerdlow SH (2008) Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma. Am J Surg Pathol 32(11):1643–1653PubMedCrossRef

43.

Gagyi E, Balogh Z, Bödör C, Timár B, Reiniger L, Deák L, Csomor J, Csernus B, Szepesi A, Matolcsy A (2008) Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression. Haematologica 93(12):1822–1828PubMedCrossRef

44.

Hunt KE, Hall B, Reichard KK (2009) Translocations involving MUM1 are rare in diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol (in press)

45.

d’Amore F, Chan E, Iqbal J, Geng H, Young K, Xiao L, Hess MM, Sanger WG, Smith L, Wiuf C, Hagberg O, Fu K, Chan WC, Dave BJ (2008) Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution. Clin Cancer Res 14(22):7180–7187PubMedCrossRef

46.

Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P, Bellan C, van Rijk A, Nyagol J, Byakika B, Lazzi S, Tosi P, van Krieken H, Leoncini L (2008) MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol 216(4):440–450PubMedCrossRef

47.

Salaverria I, Zettl A, Beà S, Hartmann EM, Dave SS, Wright GW, Boerma EJ, Kluin PM, Ott G, Chan WC, Weisenburger DD, Lopez-Guillermo A, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Jaffe ES, Staudt LM, Müller-Hermelink HK, Campo E, Rosenwald A (2008) Leukemia and Lymphoma Molecular Profiling Project (LLMPP). Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt’s lymphoma. Haematologica 93(9):1327–1334PubMedCrossRef

48.

Bonzheim I, Geissinger E, Tinguely M, Roth S, Grieb T, Reimer P, Wilhelm M, Rosenwald A, Müller-Hermelink HK, Rüdiger T (2008) Evaluation of FoxP3 expression in peripheral T-cell lymphoma. Am J Clin Pathol 130(4):613–619PubMedCrossRef

49.

Feldman AL, Law M, Remstein ED, Macon WR, Erickson LA, Grogg KL, Kurtin PJ, Dogan A (2009) Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia (in press)

50.

Tjon JM, Verbeek WH, Kooy-Winkelaar YM, Nguyen BH, van der Slik AR, Thompson A, Heemskerk MH, Schreurs MW, Dekking LH, Mulder CJ, van Bergen J, Koning F (2008) Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood 112(13):5103–10PubMedCrossRef

51.

Bovio IM, Allan RW (2008) The expression of myeloid antigens CD13 and/or CD33 is a marker of ALK+ anaplastic large cell lymphomas. Am J Clin Pathol 130(4):628–634PubMedCrossRef

52.

Kong YY, Dai B, Kong JC, Zhou XY, Lu HF, Shen L, Du X, Shi DR (2008) Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol 32(10):1495–502PubMedCrossRef

53.

Schwartz EJ, Molina-Kirsch H, Zhao S, Marinelli RJ, Warnke RA, Natkunam Y (2008) Immunohistochemical characterization of nasal-type extranodal NK/T-cell lymphoma using a tissue microarray: an analysis of 84 cases. Am J Clin Pathol 130(3):343–351PubMedCrossRef

54.

Riou-Gotta MO, Fournier E, Mermet I, Pelletier F, Humbert P, Danzon A, Aubin F (2008) Primary cutaneous lymphomas: a population-based descriptive study of 71 consecutive cases diagnosed between 1980 and 2003. Leuk Lymphoma 49(8):1537–1544PubMedCrossRef

55.

van Maldegem F, van Dijk R, Wormhoudt TA, Kluin PM, Willemze R, Cerroni L, van Noesel CJ, Bende RJ (2008) The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment. Blood 112(8):3355–3361PubMedCrossRef

56.

Kempf W, Ostheeren-Michaelis S, Paulli M, Lucioni M, Wechsler J, Audring H, Assaf C, Rüdiger T, Willemze R, Meijer CJ, Berti E, Cerroni L, Santucci M, Hallermann C, Berneburg M, Chimenti S, Robson A, Marschalko M, Kazakov DV, Petrella T, Fraitag S, Carlotti A, Courville P, Laeng H, Knobler R, Golling P, Dummer R, Burg G (2008) Cutaneous lymphoma histopathology task force group of the European Organization for Research and Treatment of cancer. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the cutaneous lymphoma histopathology task force group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol 144(12):1609–1617PubMedCrossRef

57.

Sato Y, Ohshima K, Ichimura K, Sato M, Yamadori I, Tanaka T, Takata K, Morito T, Kondo E, Yoshino T (2008) Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int 58(8):465–470PubMedCrossRef

58.

Gładkowska-Dura M, Dzierzanowska-Fangrat K, Dura WT, van Krieken JH, Chrzanowska KH, van Dongen JJ, Langerak AW (2008) Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation. J Pathol 216(3):337–344PubMedCrossRef

59.

Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, Xu W, Tan B, Goldschmidt N, Iqbal J, Vose J, Bast M, Fu K, Weisenburger DD, Greiner TC, Armitage JO, Kyle A, May L, Gascoyne RD, Connors JM, Troen G, Holte H, Kvaloy S, Dierickx D, Verhoef G, Delabie J, Smeland EB, Jares P, Martinez A, Lopez-Guillermo A, Montserrat E, Campo E, Braziel RM, Miller TP, Rimsza LM, Cook JR, Pohlman B, Sweetenham J, Tubbs RR, Fisher RI, Hartmann E, Rosenwald A, Ott G, Muller-Hermelink HK, Wrench D, Lister TA, Jaffe ES, Wilson WH, Chan WC, Staudt LM (2008) Lymphoma/Leukemia Molecular Profiling Project. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359(22):2313–2323PubMedCrossRef

60.

Wong KK, Prepageran N, Peh SC (2008) Prognostic subgroup distribution in diffuse large B-cell lymphoma of the upper aerodigestive tract. Pathology 29:1–7CrossRef

61.

Dunphy CH, O’Malley DP, Cheng L, Fodrie TY, Perkins SL, Kaiser-Rogers KK (2008) Primary mediastinal B-cell lymphoma: detection of bcl-2 gene rearrangements by PCR analysis and FISH. J Hematopathol 1:77–84CrossRef

62.

Kleinschmidt-DeMasters BK, Damek DM, Lillehei KO, Dogan A, Giannini C (2008) Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications. J Neuropathol Exp Neurol 67(11):1103–1111PubMedCrossRef

63.

Katzenberger T, Kalla J, Leich E, Stocklein H, Hartmann E, Barnickel S, Wessendorf S, Ott MM, Muller-Hermelink HK, Rosenwald A, Ott G (2009) A distinctive subtype of t(14;18) negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36. Blood 113(5):1053–1061

64.

Booman M, Szuhai K, Rosenwald A, Hartmann E, Kluin-Nelemans H, de Jong D, Schuuring E, Kluin P (2008) Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways. J Pathol 216(2):209–217PubMedCrossRef

65.

Sato Y, Onishi N, Morito T, Takata K, Mizobuchi K, Nagatsuka H, Ichimura K, Tanaka T, Tamura M, Yoshino T (2009) Patients with localized primary non-tonsillar oral diffuse large B-cell lymphoma exhibit favorable prognosis despite a non-germinal center B-cell-like phenotype. Cancer Sci 100(1):42–46

66.

Magro CM, Schaefer JT, Morrison C, Porcu P (2008) Atypical lymphocytic lobular panniculitis: a clonal subcutaneous T-cell dyscrasia. J Cutan Pathol 35(10):947–954PubMedCrossRef

67.

Akiyama T, Okino T, Konishi H, Wani Y, Notohara K, Tsukayama C, Tsunoda T, Tasaka T, Masaki Y, Sugihara T, Sadahira Y (2008) CD8+, CD56+ (natural killer-like) T-cell lymphoma involving the small intestine with no evidence of enteropathy: clinicopathology and molecular study of five Japanese patients. Pathol Int 58(10):626–634PubMedCrossRef

68.

de Jong D, Vasmel WL, de Boer JP, Verhave G, Barbé E, Casparie MK, van Leeuwen FE (2008) Anaplastic large-cell lymphoma in women with breast implants. JAMA 300(17):2030–2035PubMedCrossRef

69.

Mosunjac MB, Sundstrom JB, Mosunjac MI (2008) Unusual presentation of anaplastic large cell lymphoma with clinical course mimicking fever of unknown origin and sepsis: autopsy study of five cases. Croat Med J 49(5):660–668PubMedCrossRef

70.

Rodríguez-Pinilla SM, Atienza L, Murillo C, Pérez-Rodríguez A, Montes-Moreno S, Roncador G, Pérez-Seoane C, Domínguez P, Camacho FI, Piris MA (2008) Peripheral T-cell lymphoma with follicular T-cell markers. Am J Surg Pathol 32(12):1787–1799PubMedCrossRef

71.

LaCasce AS, Kho ME, Friedberg JW, Niland JC, Abel GA, Rodriguez MA, Czuczman MS, Millenson MM, Zelenetz AD, Weeks JC (2008) Comparison of referring and final pathology for patients with non-Hodgkin’s lymphoma in the National Comprehensive Cancer Network. J Clin Oncol 26(31):5107–5112PubMedCrossRef

72.

Kojima M, Shimizu K, Ikota H, Ohno Y, Motoori T, Itoh H, Masawa N, Nakamura S (2008) “Follicular Variant” of Hyaline-vascular Type of Castleman’s Disease: histopathological and Immunohistochemical Study of 11 Cases. J Clin Exp Hematop 48(2):39–45PubMedCrossRef

73.

Wang J, Chen C, Lau S, Raghavan RI, Rowsell EH, Said J, Weiss LM, Huang Q (2009) CD3-positive Large B-cell Lymphoma. Am J Surg Pathol (in press)

74.

Rahemtullah A, Longtine JA, Harris NL, Dorn M, Zembowicz A, Quintanilla-Fend L, Preffer FI, Ferry JA (2008) CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature. Am J Surg Pathol 32(11):1593–1607PubMedCrossRef

75.

Schreck S, Friebel D, Buettner M, Distel L, Grabenbauer G, Young LS, Niedobitek G (2008) Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma. Hematol Oncol (in press)

76.

Dong G, Liu C, Ye H, Gong L, Zheng J, Li M, Huang X, Huang X, Huang Y, Shi Y, Yin W, Gao Z (2008) BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma. Int J Hematol 88(5):516–523PubMedCrossRef

77.

Wang X, ASP Lund AC, Porwit A, Flygare J, Smith CI, Christensson B, Sander B (2008) The subcellular Sox11 distribution pattern identifies subsets of mantle cell lymphoma: correlation to overall survival. Br J Haematol 143(2):248–252PubMedCrossRef

78.

Sar A, Perizzolo M, Stewart D, Mansoor A, Difrancesco LM, Demetrick DJ (2009) Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients. Leuk Res (in press)

79.

Aktaş S, Kargı A, Olgun N, Diniz G, Erbay A, Vergin C (2009) Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein–Barr virus positive and negative pediatric non-Hodgkin’s lymphoma. Pathol Oncol Res (in press)

80.

Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, Carty S, Lam LT, Shaffer AL, Xiao W, Powell J, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Connors JM, Campo E, Jaffe ES, Delabie J, Smeland EB, Rimsza LM, Fisher RI, Weisenburger DD, Chan WC, Staudt LM (2008) Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA 105(36):13520–13525PubMedCrossRef

81.

Peh SC, Gan GG, Lee LK, Eow GI (2008) Clinical relevance of CD10, BCL-6 and multiple myeloma-1 expression in diffuse large B-cell lymphomas in Malaysia. Pathol Int 58(9):572–579PubMedCrossRef

82.

Johnson NA, Boyle M, Bashashati A, Leach S, Brooks-Wilson A, Sehn LH, Chhanabhai M, Brinkman RR, Connors JM, Weng AP, Gascoyne RD (2009) Diffuse large B cell lymphoma: reduced CD20 expression is associated with an inferior survival. Blood (in press)

83.

Hsi ED, Jung SH, Lai R, Johnson JL, Cook JR, Jones D, Devos S, Cheson BD, Damon LE, Said J (2008) Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study. Leuk Lymphoma 49(11):2081–2090PubMedCrossRef

84.

Hasselblom S, Ridell B, Sigurdardottir M, Hansson U, Nilsson-Ehle H, Andersson PO (2008) Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma. Leuk Lymphoma 49(8):1501–1509PubMedCrossRef

85.

Jang KY, Hwang SH, Kwon KS, Kim KR, Choi HN, Lee NR, Kwak JY, Park BH, Park HS, Chung MJ, Kang MJ, Lee DG, Kim HS, Shim H, Moon WS (2008) SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma. Am J Surg Pathol 32(10):1523–1531PubMedCrossRef

86.

Johnson NA, Al-Tourah A, Brown CJ, Connors JM, Gascoyne RD, Horsman DE (2008) Prognostic significance of secondary cytogenetic alterations in follicular lymphomas. Genes Chromosomes Cancer 47(12):1038–1048PubMedCrossRef

87.

Hasselblom S, Hansson U, Sigurdardottir M, Nilsson-Ehle H, Ridell B, Andersson PO (2008) Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis. Pathol Int 58(8):529–532PubMedCrossRef

88.

Aggarwal M, Villuendas R, Gomez G, Rodriguez-Pinilla SM, Sanchez-Beato M, Alvarez D, Martinez N, Rodriguez A, Castillo ME, Camacho FI, Montes-Moreno S, Garcia-Marco JA, Kimby E, Pisano DG, Piris MA (2009) TCL1A expression delineates biological and clinical variability in B-cell lymphoma. Mod Pathol 22(2):206–215

89.

Klapper W, Stoecklein H, Zeynalova S, Ott G, Kosari F, Rosenwald A, Loeffler M, Trümper L, Pfreundschuh M, Siebert R (2008) German High-Grade Non-Hodgkin’s Lymphoma Study Group. Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL). Leukemia 22(12):2226–2229PubMedCrossRef

90.

Yoon SO, Jeon YK, Paik JH, Kim WY, Kim YA, Kim JE, Kim CW (2008) MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type. Histopathology 53(2):205–217PubMedCrossRef

91.

Wang B, Li XQ, Ma X, Hong X, Lu H, Guo Y (2008) Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK/T-cell lymphoma, nasal type. Am J Hematol 83(10):795–799PubMedCrossRef

92.

Seegmiller AC, Karandikar NJ, Kroft SH, McKenna RW, Xu Y (2009) Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytes. Cytometry B Clin Cytom (in press)

93.

Pierson DM, Jones D, Muzzafar T, Kersh MJ, Challagundla P, Medeiros LJ, Jorgensen JL (2008) Utility of CD26 in flow cytometric immunophenotyping of T-cell lymphomas in tissue and body fluid specimens. Cytometry B Clin Cytom 74(6):341–348PubMed

94.

van Rijk A, Mason D, Jones M, Cabeçadas J, Crespo M, Cigudosa JC, Garcia JF, Leoncini L, Cocco M, Hansmann M-L, Mottok A, Bergman CC, Gaulard P, Anagnostou D, Pouliou E, Dutoit SH, Christiansen MH, Mathiessen S, Poulsen TS, van Dongen J, van Krieken JH (2008) Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach. J Hematopathol 1:119–126CrossRef

95.

Flanagan MB, Sathanoori M, Surti U, Soma L, Swerdlow SH (2008) Cytogenetic abnormalities detected by fluorescence in situ hybridization on paraffin-embedded chronic lymphocytic leukemia/small lymphocytic lymphoma lymphoid tissue biopsy specimens. Am J Clin Pathol 130(4):620–627PubMedCrossRef

96.

Huh HJ, Min HC, Cho HI, Chae SL, Lee DS (2008) Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis. Cancer Genet Cytogenet 186(1):1–5PubMedCrossRef

97.

Groenen PJTA, Langerak AW, van Dongen JJM, van Krieken JHJM (2008) Pitfalls in TCR gene clonality testing: teaching cases. J Hematopathol 1:97–109CrossRef

98.

Santón A, García-Cosio M, Bellosillo B, Rodríguez P, Cristóbal E, Serrano S, Besses C, Abraira V, Salar A, Montalbán C (2008) Persistent monoclonality after histological remission in gastric mucosa-associated lymphoid tissue lymphoma treated with chemotherapy and/or surgery: influence of t(11;18)(q21;q21). Leuk Lymphoma 49(8):1516–1522PubMedCrossRef

99.

Morales AV, Arber DA, Seo K, Kohler S, Kim YH, Sundram UN (2008) Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates. Am J Dermatopathol 30(5):425–430PubMedCrossRef

100.

Tan BT, Seo K, Warnke RA, Arber DA (2008) The frequency of immunoglobulin heavy chain gene and T-cell receptor gamma-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK- anaplastic large cell lymphoma and other peripheral T-cell lymphomas. J Mol Diagn 10(6):502–512PubMedCrossRef

101.

Pai RK, Mullins FM, Kim YH, Kong CS (2008) Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies. Cancer 114(5):323–332PubMedCrossRef

102.

Caraway NP, Thomas E, Khanna A, Payne L, Zhang HZ, Lin E, Keating MJ, Katz RL (2008) Chromosomal abnormalities detected by multicolor fluorescence in situ hybridization in fine-needle aspirates from patients with small lymphocytic lymphoma are useful for predicting survival. Cancer 114(5):315–322PubMedCrossRef

Keynote webinar | Spotlight on medication adherence

Springer Medicine

New developments in the pathology of malignant lymphoma: a review of the literature published from August to December 2008

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2009

Highlights of 2008 in bone marrow biopsy pathology

Analysis of Aurora kinase A expression in CD34+ blast cells isolated from patients with myelodysplastic syndromes and acute myeloid leukemia

Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer

The second year of the Journal of Hematopathology has started

Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia

Prognostic impact of C-REL expression in diffuse large B-cell lymphoma